Cyclooxygenase-2 and selenium in breast cancer | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Cyclooxygenase-2 and selenium in breast cancer

Author(s): Faten Z Mohameda, Talaat M. El-Mokademb, Marwa S. Sabeaa and Ahmed H. Attiaa

Breast cancer is a global problem that accounts for nearly a quarter of all cancers in women. Recent studies implicated expression of cyclooxygenase-2 as a marker to identify precursor cells for breast cancer. The purpose of the present work is to investigate the association of genotypic polymorphisms in cyclooxygenase-2 and selenium with breast cancer. Methods: investigation of genotypic polymorphisms of cyclooxygenase-2, measurement of selenium by electrothermal atomic absorption spectrometry (ET-AAS) and investigation of calcium and alkaline phosphatase spectrophotometry in 500 patients with breast cancer and 100 healthy controls from Zagazig University Hospital in Egypt. The results showed significant differences in distribution between the breast cancer and controls. We found 169G allele carriers had a higher risk of breast cancer and results also showed significant decrease in Se and Ca and significant increase in Alk. In conclusion: the G allele of COX-2 gene may be a good marker in breast cancer and evaluation of serum Se, Ca and AlP give a red light in early detection of breast cancer.


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank